Bausch Health Companies (BHC) vs Cronos Group (CRON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cronos Group (CRON) has outperformed Bausch Health Companies (BHC) over the past year, gaining 20.1% versus a loss of 4.7%. Over five years, CRON leads with a -41.2% price change compared with -78.8% for BHC. Bausch Health Companies is the larger company by market cap ($2.26 billion vs $1.19 billion), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BHC | CRON |
|---|---|---|
| Share price | $6.04 | $3.22 |
| Market cap | $2.26B | $1.19B |
| 1-day change | -1.79% | -0.62% |
| YTD return | -13.09% | +22.43% |
| 1-year return | -4.73% | +20.15% |
| 5-year return | -78.80% | -41.24% |
| P/E ratio (TTM) | — | 16.95 |
| Forward P/E | 1.44 | — |
| EPS (TTM) | $-2.90 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.00 | $3.61 |
| 52-week low | $4.33 | $2.28 |
| Distance from 52-week high | -24.50% | -10.75% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +24.17% | -23.29% |
| Average volume | 3.24M | 1.13M |
| Shares outstanding | 373.99M | 368.41M |
| Employees | 20,300 | 610 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CRON has outperformed BHC by 24.9 percentage points over the past year.
- The two companies sit in different sectors: Bausch Health Companies in Health Care and Cronos Group in Healthcare.
About Bausch Health Companies
BHC stock →Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Health Care · Biotechnology: Pharmaceutical Preparations · 20,300 employees
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Healthcare · Drug Manufacturers - Specialty & Generic · 610 employees
BHC vs CRON FAQ
Which is bigger, Bausch Health Companies or Cronos Group?
Bausch Health Companies (BHC) is larger, with a market capitalization of $2.26B compared with $1.19B for Cronos Group (CRON).
Which stock has performed better over the past year, BHC or CRON?
CRON returned +20.15% over the past 12 months, compared with -4.73% for BHC (price return, excluding dividends). Past performance does not predict future results.
Are Bausch Health Companies and Cronos Group in the same industry?
No. Bausch Health Companies is in the Health Care sector, while Cronos Group is in Healthcare.